Our Vision

Discover MediTrans’ vision and mission built on expertise, accuracy, reliability and innovation.

Vision & Mission

Vision

To remove language barriers in the global pharma and biotech industry
and become a leading partner for medical innovation worldwide.

Mission

To support clients’ global development and approval success through integrated
medical writing, clinical/regulatory documentation, and specialist translation services.

Core values

Expertise

Deep domain knowledge and extensive experience in medical and life sciences.

Accuracy

Precise terminology and quality‑assured deliverables for every project.

Reliability

Consistent high quality and on‑time delivery you can depend on.

Innovation

Continuous improvement using modern tools, workflows, and data‑driven methods.

Frequently asked questions

MediTrans is a clinical and regulatory communication partner for CROs and pharmaceutical companies, with medical writing as its core expertise.

What is MediTrans' primary expertise?

Our primary expertise is medical writing for clinical and regulatory documentation, supported by specialist translation for global submissions.

Why do CROs and pharmaceutical companies work with MediTrans?

We help reduce communication risks in global development and approval workflows by ensuring document consistency, terminology accuracy, and regulatory readiness.

Which services are included in clinical/regulatory communication support?

Our support includes medical writing, clinical and regulatory documentation, audit/inspection interpretation support, and multilingual communication for global stakeholders.

How is Doctor's Note positioned in your portfolio?

Doctor's Note is a digital expansion initiative built on our core B2B expertise, not a replacement for our core CRO/pharma-focused services.

CEO Message

Your language partner for global medical innovation

MediTrans is a specialized clinical and regulatory communication partner for CROs and pharmaceutical companies. We deliver integrated medical writing, clinical/regulatory documentation, and specialist translation support to ensure consistent document quality and communication accuracy from development through approval.

Our team combines experience in medicine, pharmaceuticals, and life sciences with strong linguistic skills to support pharmaceutical companies, research institutions, and healthcare providers. We adhere to international regulatory and quality standards while handling a wide range of documents, from clinical and regulatory materials to medical communications.

In a rapidly evolving global life‑science landscape, MediTrans is committed to being a trusted partner that supports your long‑term success.

Chief Executive Officer

Giai Kwon

Organization

Chief Executive Officer

Business Operations

HR (including expert network management), administration, finance

Sales & Marketing

Sales, marketing, client success

Medical Writing & Translation

Medical content authoring & review, clinical/regulatory documentation, localization

Technology & Platform

Platform development, IT operations

History

2026

Strengthened core services and launched Doctor's Note app

Expanded our core portfolio by reinforcing medical writing and DM/STAT services.
Launched Doctor's Note, a notarized translation request app for medical records, diagnostic reports, and medical opinions, on Android and iOS.

2025

Expansion of global service portfolio

Launched on‑site interpretation support for regulatory audits and inspections in pharma and biotech.
Opened a B2C platform to better serve individual researchers and consumers.

2024

International certification & advanced services

Official launch of medical writing services, building end‑to‑end capability for clinical documentation.
Obtained ISO 9001:2015 quality management certification.
Joined the American Translators Association (ATA), expanding our global professional network.

2023

Introduction of global marketing solutions

Launched integrated marketing support services for companies entering overseas markets.
Strengthened clients’ global competitiveness through multilingual website localization and IR translation.

2022

Brand identity refresh

Changed the company name from “Kbon Solutions” to “MediTrans” to clarify our positioning
as a specialist language partner for the pharma and biotech industry and strengthen our global brand.

2021

Completion of global expert network

Built a network of over 200 licensed medical and life‑science professionals.
Secured coverage across Asia, Europe, and the Americas.

2020

Company founded & services launched

Founded as Kbon Solutions and launched clinical/regulatory communication services for pharma and biotech.
Entered the market by supporting urgent vaccine-related documentation and communication needs during the COVID‑19 pandemic.

Certifications

2024-

ISO 9001:2015 Quality Management System

International Organization for Standardization (ISO)

2025

Member, American Translators Association (ATA)

American Translators Association